Blaine Davis serves as Executive at Protara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Blaine Davis has executed 4 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2024 involved receiving (via award) 2,424,000 shares valued at $0.
Blaine Davis currently holds 2,424,000 shares of Protara Therapeutics, Inc. (TARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Blaine Davis has been a net buyer of TARA stock. They have purchased $25.0K and sold $0 worth of shares.
Blaine Davis's most recent insider trade was on Jan 2, 2024, when they sold 2,424,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.13 |
| Discretionary |
| Jan 3, 2022 | TARA | $0 | Award | 14,100 | $N/A | Discretionary |
| Sep 22, 2020 | TARA | $25.0K | Purchase | 1,481 | $16.91 | Discretionary |